Circulating Metabolites and Tumor-derived Extravesicular Proteins in Small Cell Lung Cancer
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Written and signed informed consent
• Histopathologically and/or cytologically newly-diagnosed SCLC
• Measurable disease on CT scans
• Eligibility to receive standard chemotherapy consisting of carboplatin and etoposide
Locations
Other Locations
Denmark
Aalborg University Hospital
RECRUITING
Aalborg
Contact Information
Primary
Borgen Dalsgaard
anbd@rn.dk
97606989
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Leads: Aalborg University Hospital